Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer.
| Autor: | Ready N, Karaseva NA, Orlov SV, Luft AV, Popovych O, Holmlund JT, Wood BA, Leopold L |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2011 Apr, Vol. 6 Issue 4, p781-785, 5p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|